p.62 抽出テキスト

ents. Eur J Cardiothorac Surg 2011; 40: 971-977. PMID: 21354812 132. Mikus E, Stepanenko A, Krabatsch T, et al. Left ventricular assist device or heart transplantation: impact of transpulmonary gradient and pulmonary vascular resistance on decision making. Eur J Cardiothorac Surg 2011; 39: 310-316. PMID: 20615720 133. Asleh R, Briasoulis A, Schettle SD, et al. Impact of diabetes mellitus on outcomes in patients supported with left ventricular assist devices: A single institutional 9-year experience. Circ Heart Fail 2017; 10: e004213. PMID: 29141856 134. Yassin AS, Subahi A, Adegbala O, et al. Clinical impact of diabetes mellitus on short-term outcomes and in-hospital mortality of cardiac mechanical support with left ventricular assist device (LVAD): A retrospective study from a National Database. Cardiovasc Revasc Med 2019; 20: 883-886. PMID: 30578171 135. Kusne S, Mooney M, Danziger-Isakov L, et al. An ISHLT consensus document for prevention and management strategies for mechanical circulatory support infection. J Heart Lung Transplant 2017; 36: 1137-1153. PMID: 28781010 136. Cowger J, Sundareswaran K, Rogers JG, et al. Predicting survival in patients receiving continuous flow left ventricular assist devices: the HeartMate II risk score. J Am Coll Cardiol 2013; 61: 313-321. PMID: 23265328 137. Michaels A, Cowger J. Patient selection for destination LVAD therapy: predicting success in the short and long term. Curr Heart Fail Rep 2019; 16: 140-149. PMID: 31240639 138. Truby LK, Garan AR, Givens RC, et al. Aortic Insufficiency during contemporary left ventricular assist device support: analysis of the INTERMACS Registry. JACC Heart Fail 2018; 6: 951-960. PMID: 30384913 139. Toda K, Fujita T, Domae K, et al. Late aortic insufficiency related to poor prognosis during left ventricular assist device support. Ann Thorac Surg 2011; 92: 929-934. PMID: 21871279 140. Imamura T, Kinugawa K, Fujino T, et al. Aortic insufficiency in patients with sustained left ventricular systolic dysfunction after axial flow assist device implantation. Circ J 2015; 79: 104-111. PMID: 25381791 141. Feldman CM, Silver MA, Sobieski MA, et al. Management of aortic insufficiency with continuous flow left ventricular assist devices: bioprosthetic valve replacement. J Heart Lung Transplant 2006; 25: 1410-1412. PMID: 17178333 142. Fukuhara S, Takeda K, Chiuzan C, et al. Concomitant aortic valve repair with continuous-flow left ventricular assist devices: Results and implications. J Thorac Cardiovasc Surg 2016; 151: 201-210. PMID: 26699773 143. Robertson JO, Naftel DC, Myers SL, et al. Concomitant aortic valve procedures in patients undergoing implantation of continuous-flow left ventricular assist devices: An INTERMACS database analysis. J Heart Lung Transplant 2015; 34: 797-805. PMID: 25511747 144. Rao V, Slater JP, Edwards NM, et al. Surgical management of valvular disease in patients requiring left ventricular assist device support. Ann Thorac Surg 2001; 71: 1448-1453. PMID: 11383781 145. Goda A, Takayama H, Pak SW, et al. Aortic valve procedures at the time of ventricular assist device placement. Ann Thorac Surg 2011; 91: 750-754. PMID: 21352992 146. Tasset MR, Kavarana MN, Gray LA, et al. Simple mechanical aortic valve closure in ventricular assist device recipients. Ann Thorac Surg 2006; 82: 316-318. PMID: 16798240 147. Adamson RM, Dembitsky WP, Baradarian S, et al. Aortic valve closure associated with HeartMate left ventricular device support: technical considerations and long-term results. J Heart Lung Transplant 2011; 30: 576-582. PMID: 21256765 148. Tisol WB, Mueller DK, Hoy FB, et al. Ventricular assist device use with mechanical heart valves: an outcome series and literature review. Ann Thorac Surg 2001; 72: 2051-2055. PMID: 11789792 149. Swartz MT, Lowdermilk GA, Moroney DA, et al. Ventricular assist device support in patients with mechanical heart valves. Ann Thorac Surg 1999; 68: 2248-2251. PMID: 10617011 150. Matsumiya G, Miyamoto Y, Monta O, et al. Left ventricular restoration for ischemic cardiomyopathy and simultaneous implantation of left ventricular assist system actively aiming at bridge to recovery. J Thorac Cardiovasc Surg 2005; 130: 219-220. PMID: 15999071 151. Osaki S, Edwards NM, Kohmoto T. Strategies for left ventricular assist device insertion after the Dor procedure. J Heart Lung Transplant 2009; 28: 520-522. PMID: 19416785 152. Takeda K, Ahmad U, Malaisrie SC, et al. Successful implantation of HeartWare HVAD left ventricular assist device with concomitant ascending and sinus of valsalva aneurysms repair. J Artif Organs 2012; 15: 204-206. PMID: 22327244 153. Kiernan MS, Grandin EW, Brinkley M Jr, et al. Early right ventricular assist device use in patients undergoing continuous-flow left ven- tricular assist device implantation: Incidence and risk factors from the Interagency Registry for Mechanically Assisted Circulatory Support. Circ Heart Fail 2017; 10: e003863. PMID: 29021348 154. Yoshioka D, Toda K, Ono M, et al. Japanese HeartMateII Investigators. Clinical results, adverse events, and change in end-organ function in elderly patients with HeartMateII left ventricular assist device - Japanese Multicenter Study. Circ J 2018; 82: 409-418. PMID: 29057766 155. Sakaguchi T, Saito S, Yoshioka D, et al. Long-term biventricular support with rotary blood pumps in a patient with a noncontractile heart. J Thorac Cardiovasc Surg 2013; 146: e29-e30. PMID: 23871142 156. Yoshioka D, Toda K, Yoshikawa Y, et al. Over 1200-day support with dual Jarvik 2000 biventricular assist device. Interact Cardiovasc Thorac Surg 2014; 19: 1083-1084. PMID: 25228243 157. Saito S, Toda K, Nakamura T, et al. Rescuing patients with severe biventricular failure in the era of continuous-flow left ventricular assist device. Circ J 2019; 83: 379-385. PMID: 30531119 158. Takeda K, Naka Y, Yang JA, et al. Outcome of unplanned right ventricular assist device support for severe right heart failure after implantable left ventricular assist device insertion. J Heart Lung Transplant

2014; 33: 141-148. PMID: 23932442 159. Yoshioka D, Takayama H, Garan RA, et al. Contemporary outcome of unplanned right ventricular assist device for severe right heart failure after continuous-flow left ventricular assist device insertion. Interact Cardiovasc Thorac Surg 2017; 24: 828-834. PMID: 28329284 160. Kormos RL, Cowger J, Pagani FD, et al. The Society of Thoracic Surgeons Intermacs database annual report: Evolving indications, outcomes, and scientific partnerships. J Heart Lung Transplant 2019; 38: 114-126. PMID: 30691593 161. DeVore AD, Hammill BG, Patel CB, et al. Intra-Aortic Balloon Pump Use Before Left Ventricular Assist Device Implantation: Insights From the INTERMACS Registry. ASAIO J 2018; 64: 218-224. PMID: 29470245 162. Crespo-Leiro MG, Metra M, Lund LH, et al. Advanced heart failure: a position statement of the Heart Failure Association of the European Society of Cardiology. Eur J Heart Fail 2018; 20: 1505-1535. PMID: 29806100 163. Krishnamurthy Y, Cooper LB, Parikh KS, et al. Pulmonary Hypertension in the Era of Mechanical Circulatory Support. ASAIO J 2016; 62: 505-512. PMID: 27442856 164. Lampert BC, Teuteberg JJ. Right ventricular failure after left ventricular assist devices. J Heart Lung Transplant 2015; 34: 1123-1130. PMID: 26267741 165. Gulati G, Grandin EW, Kennedy K, et al. Preimplant Phosphodiesterase-5 Inhibitor Use Is Associated With Higher Rates of Severe Early Right Heart Failure After Left Ventricular Assist Device Implantation. Circ Heart Fail 2019; 12: e005537. PMID: 31181953 166. Mehra MR, Canter CE, Hannan MM, et al. ISHLT Infectious Diseases, Pediatric and Heart Failure and Transplantation Councils. The 2016 International Society for Heart Lung Transplantation listing criteria for heart transplantation: A 10-year update. J Heart Lung Transplant 2016; 35: 1-23. PMID: 26776864 167. Imamura T, Kinugawa K, Shiga T, et al. Correction of hyponatremia by tolvaptan before left ventricular assist device implantation. Int Heart J 2012; 53: 391-393. PMID: 23258142 168. Matthews JC, Pagani FD, Haft JW, et al. Model for end-stage liver disease score predicts left ventricular assist device operative transfusion requirements, morbidity, and mortality. Circulation 2010; 121: 214-220. PMID: 20048215 169. Shiga T, Kinugawa K, Hatano M, et al. Age and preoperative total bilirubin level can stratify prognosis after extracorporeal pulsatile left ventricular assist device implantation. Circ J 2011; 75: 121-128. PMID: 21116070 170. Imamura T, Kinugawa K, Hatano M, et al. Low cardiac output stimulates vasopressin release in patients with stage d heart failure. - Its Relevance to Poor Prognosis and Reversal by Surgical Treatment. Circ J 2014; 78: 2259-2267. PMID: 25008779 171. Imamura T, Kinugawa K, Minatsuki S, et al. Urine osmolality estimated using urine urea nitrogen, sodium and creatinine can effectively predict response to tolvaptan in decompensated heart failure patients. Circ J 2013; 77: 1208-1213. PMID: 23318562 172. Imamura T. Aquaporin-2-guided tolvaptan therapy in patients with congestive heart failure accompanied by chronic kidney disease. Int Heart J 2014; 55: 482-483. PMID: 25318555 173. Imamura T, Kinugawa K. Update of acute and long-term tolvaptan therapy. J Cardiol 2019; 73: 102-107. PMID: 30420105 174. Lietz K, Long JW, Kfoury AG, et al. Outcomes of left ventricular assist device implantation as destination therapy in the post-REMATCH era: implications for patient selection. Circulation 2007; 116: 497- 505. PMID: 17638928